NY Decries 'Brazen Gaslighting' By Endo's Opioid Attys
The New York Attorney General's Office on Thursday declared that belated and begrudging disclosures by Endo Pharmaceuticals in a tumultuous opioid trial contain "case-changing" revelations and fresh evidence of misconduct by...To view the full article, register now.
Already a subscriber? Click here to view full article